Evidence-Based Management of Hypertension

Lifestyle Modifications

The American Heart Association recommends comprehensive lifestyle interventions, including weight reduction, dietary sodium restriction, and regular aerobic physical activity, for all patients with hypertension or prehypertension before or alongside pharmacological therapy 1, 2
Stress reduction, including mindfulness or meditation practices, is also recommended for patients with hypertension 3

The American College of Cardiology recommends immediate drug therapy for patients with sustained blood pressure ≥160/100 mmHg despite lifestyle measures, or for those with blood pressure 140-159/90-99 mmHg and target organ damage, established cardiovascular disease, diabetes, or 10-year CVD risk ≥20% 1, 4
For non-Black patients, single-pill combinations containing an ACE inhibitor or ARB, plus a thiazide/thiazide-like diuretic or dihydropyridine calcium channel blocker, are recommended as first-line treatment 4, 5
For Black patients, the preferred initial combination is an ARB plus a dihydropyridine calcium channel blocker or thiazide-like diuretic 4, 6

The American Heart Association recommends a standard target blood pressure of <130/80 mmHg for most adults <65 years, and <130/80 mmHg for higher-risk populations, including those with diabetes, chronic kidney disease, or established CVD 1, 2, 4
For elderly patients ≥65 years, a target systolic blood pressure of <130 mmHg is recommended if tolerated, with <140/80 mmHg being acceptable for those ≥85 years or with frailty 4, 5

If blood pressure remains uncontrolled on dual therapy, treatment should be escalated systematically, including increasing to full doses of the initial combination, adding a third agent, and considering the use of spironolactone or other additional agents 4, 5

The American College of Cardiology recommends achieving target blood pressure within 3 months, with monthly visits until controlled, and using home blood pressure monitoring for medication titration 2, 4
Team-based care and telehealth strategies should be implemented to enhance outcomes, and 90-day prescription refills should be considered to improve adherence 2, 4

The use of JVS-100 or any unproven agents for hypertension management should be avoided, as well as dual RAS blockade due to increased risks of hypotension, hyperkalemia, and renal dysfunction 5, 6
Delaying treatment in young adults with target organ damage beyond 6-12 months of lifestyle modification should also be avoided, and screening for secondary causes of hypertension should be performed in resistant hypertension or young-onset cases 1, 2